The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKore Potash Regulatory News (KP2)

Share Price Information for Kore Potash (KP2)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.525
Bid: 0.50
Ask: 0.55
Change: 0.00 (0.00%)
Spread: 0.05 (10.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.525
KP2 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fundraise of US$ 530,000

22 Mar 2024 07:00

RNS Number : 9373H
Kore Potash PLC
22 March 2024
 

22 March 2024

 

KORE POTASH PLC

("Kore Potash" or "the Company")

Fundraise of US$ 530,000

 

Kore Potash plc, the potash development company with 97% ownership of the Kola and DX Potash Projects in the Sintoukola Basin, located in the Republic of Congo, is pleased to announce that the Company has issued five separate Convertible Loan Notes ("CLNs") in the Company with an aggregate value of US$ 530,000 (the "Fundraise"). The CLNs have a proposed Drawdown date of 22 March 2024.

 

The net proceeds from the CLNs will be used to further advance work that is expected to lead to the signing of an EPC contract for the Kola Potash Project, as announced by the Company on 9 February 2024, and provide working capital for Kore Potash.

CLNsThe Company is raising US$ 530,000 by way of the issue of five separate CLNs. Each Convertible Loan has a zero interest coupon and is convertible into new ordinary shares of US$ 0.001 ("new Ordinary Shares") each in the Company at a price of 0.38 pence per new Ordinary Share and will be converted immediately after publication of the 2023 Annual Report which the Company expects to publish on or about 28 March 2024. 

Subject to the conversion of the CLNs the Company will issue 109,865,053 new Ordinary Shares in the Company. The conversion of the CLNs into shares is subject to and conditional upon the publication of the Company's Annual Report. Only upon the occurrence of an Event of Default the Lenders may, for so long as the Event of Default is continuing, by written notice to the Company declare the Outstanding Moneys to be immediately due and payable to the Lenders without the need for any further demand or notice to be given. There are no broking fees incurred in respect of this Fundraise.

Chairman's intentions

Kore Potash is currently in a close period that restricts Directors and senior management from trading in the Company's shares pending the notification of the audited results for the year ended 31 December 2023 ("Results"), which are expected to be notified on or about 28 March 2024. Subject to any regulatory requirements, it is the intention of David Hathorn, Chairman, to subscribe for new ordinary shares of the Company for a consideration of US$ 150,000 as soon as practicable following the notification of the Results on the same terms as the Fundraise. A further announcement will be made in relation to any subscription by David Hathorn in due course.

 

Related party transactions

Harlequin Investments Ltd ("Harlequin") is a substantial shareholder of the Company, holding 12.33% of the Company's issued share capital prior to the Fundraise, and has agreed to subscribe for CLNS to the value of US$ 200,000, which will convert into 41,458,510 new Ordinary Shares, upon publication of the Company's Annual Report. As a Substantial Shareholder, Harlequin's participation in the Fundraise is deemed to be a related party transaction for the purposes of AIM Rule 13. The directors of the Company, having consulted with the Company's nominated adviser, SP Angel Corporate Finance LLP, consider that the terms of Harlequin's participation in the Fundraise are fair and reasonable insofar as shareholders of the Company are concerned. Harlequin is not a related party noted under ASX Listing Rule 10.11.

 

Market Abuse Regulation

Market Abuse Regulation (MAR) Disclosure - The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which has been incorporated into UK law by the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

The Company will also lodge an Appendix 3B Proposed issue of +securities, with the ASX notifying of the proposed issues.

 

This announcement has been approved for release by the Board.

 

For further information, please visit www.korepotash.com or contact:

 

Kore Potash

David Hathorn - Chairman & Interim CEO

 

Andrey Maruta - CFO

Tel: +44 (0) 20 3963 1776

Tavistock Communications

Nick Elwes Adam Baynes

 

Tel: +44 (0) 20 7920 3150

SP Angel Corporate Finance- Nomad and Broker Ewan Leggat

Charlie Bouverat

Kasia Brzozowska

Tel: +44 (0) 20 7470 0470

Shore Capital- Joint Broker Toby Gibbs

James Thomas

Tel: +44 (0) 20 7408 4050

Questco Corporate Advisory- JSE Sponsor Doné Hattingh

Tel: +27 (11) 011 9205

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKDAALLLEEA
Date   Source Headline
7th Dec 20188:50 amRNSMining Convention passed into Law
5th Dec 20187:00 amRNSCDI Monthly Movement
21st Nov 20187:00 amRNSExtensions to Sylvinite Deposits Expected
16th Nov 201811:06 amRNSSecond Price Monitoring Extn
16th Nov 201811:00 amRNSPrice Monitoring Extension
5th Nov 20189:00 amRNSCDI Monthly Movement
1st Nov 20187:00 amRNSDefinitive Feasibility Study ("DFS") Received
30th Oct 20189:01 amRNSCashflow Report for Q3 2018
30th Oct 20189:00 amRNSReview of Operations for Q3 2018
5th Oct 20189:00 amRNSCDI Monthly Movement
1st Oct 20187:00 amRNSCompany Secretary Change
28th Sep 20187:15 amRNSDefinitive Feasibility Study Update
12th Sep 201810:15 amRNSFINANCIAL REPORT FOR HALF YEAR ENDED 30 JUNE 2018
12th Sep 20187:00 amRNSDedicated Offshore Transhipment Area Licenced
10th Sep 20189:00 amRNSCDI Monthly Movement
28th Aug 20188:30 amRNSApproval of ESIA for Dougou licence area
20th Aug 201810:00 amRNSMaiden Sylvinite MRE at Dougou Extension
7th Aug 20183:23 pmRNSDirector/PDMR Shareholding - Replacement
7th Aug 20189:32 amRNSCDI Monthly Movement
7th Aug 20189:31 amRNSDirector / PDMR Shareholdings
7th Aug 20189:30 amRNSDirector / PDMR Shareholding
2nd Aug 20187:02 amRNSDirector Interest Notice
2nd Aug 20187:01 amRNSAppendix 3B
2nd Aug 20187:00 amRNSDirector Interest Notices
31st Jul 20187:01 amRNSReview of Operations for Q2 2018
31st Jul 20187:00 amRNSCashflow Report for Q2 2018
18th Jul 20189:30 amRNSCDI Monthly Movement
27th Jun 201811:01 amRNSResults of AGM
27th Jun 201811:00 amRNSExpiry of unlisted options
12th Jun 20188:45 amRNSCDI Monthly Movement
1st Jun 20188:00 amRNSAnnual Financial Report
30th May 20187:00 amRNSAppointment of CEO
23rd May 20187:00 amRNSAppointment of a Non-Executive Director
4th May 20188:00 amRNSCDI Monthly Movement
30th Apr 20189:31 amRNSReview of Operations for Q1 2018
30th Apr 20189:30 amRNSCashflow Report for Q1 2018
26th Apr 20183:40 pmRNSAdmission Document Disclosures
26th Apr 20183:37 pmRNSHolding(s) in Company
26th Apr 20181:30 pmRNSDirector Resignation
18th Apr 201810:00 amRNSExpiry of Unlisted Options
17th Apr 20189:30 amRNSDirector/PDMR Shareholding
13th Apr 20189:00 amRNSDirector/PDMR Shareholding
10th Apr 20188:00 amRNSASX waiver in relation to quotation of CDIs
9th Apr 201810:20 amRNSDirector/PDMR Shareholding
5th Apr 20181:09 pmRNSDirector/PDMR Shareholding
4th Apr 20181:55 pmRNSNotice under Section 708A
4th Apr 20181:49 pmRNSAppendix 3B
3rd Apr 20187:00 amRNSAnnual Financial Report
29th Mar 20187:00 amRNSAdmission to AIM and JSE and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.